Day: August 21, 2024

TCM Group A/S: Interim report Q2 2024

Written by Customer Service on August 21, 2024. Posted in Earnings Releases And Operating Results.

COMPANY ANNOUNCEMENT No. 194/2024 Tvis, 21 August 2024 Interim report Q2 2024 (April 1 – June 30) (All figures in brackets refer to the corresponding period in 2023 – AUBO Production A/S is incl.in the figures as from 3 July 2023) Organic growth in sales and improved earnings, despite challenging market conditions. CEO Torben Paulin:“Sales in the second quarter have developed positively despite the, as expected, weak B2B-kitchen market. Organically sales grew by 5% year-on-year supported by a growth in B2C sales of more than 25% y-o-y. As expected B2B sales declined in the quarter due to the slowdown in the Project sales market. Overall revenue in Q2 was DKK 332 million compared to DKK 256 million in Q2 last year. Sales in Denmark, which accounts for 80% of the Group revenue, increased by 15%, with an underlying organic...

Ultimovacs ASA Reports Second Quarter 2024 Financial Results and Provides General Business Update

Written by Customer Service on August 21, 2024. Posted in Earnings Releases And Operating Results.

Oslo, August 21, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces its second quarter 2024 results today. Conference call and webcast scheduled for August 21, 2024, at 14:00 (CET). Link to webcast here. Second Quarter 2024 Business UpdateFollowing the negative INITIUM result in March 2024, Ultimovacs implemented cash preservation initiatives during the second quarter of 2024 extending the anticipated cash runway to the fourth quarter of 2025, beyond the topline readout of the FOCUS trial and the anticipated topline readout of the DOVACC trial. In August 2024, Ultimovacs reported topline results from the Phase II FOCUS trial in head and neck cancer. The trial did not meet the primary endpoint of improved progression-free survival...

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

Written by Customer Service on August 21, 2024. Posted in Public Companies.

Allschwil, Switzerland, August 21, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued strong sales performance of the antifungal Cresemba® (isavuconazole) by its license partner Pfizer Inc. in the Asia Pacific region and China exceeded the sales threshold triggering a USD 1.25 million milestone payment. David Veitch, Basilea’s Chief Executive Officer, stated: “Achieving the threshold for the third milestone payment for Asia Pacific and China this year, underscores the strong sales performance and growth of Cresemba in this region. We are pleased that Cresemba continues to meet the medical needs of patients suffering from life-threatening invasive mold infections.” The...

Prosafe SE: Safe Boreas contract signed

Written by Customer Service on August 21, 2024. Posted in Public Companies.

21 August 2024 – Reference is made to press release dated 30 May 2024 where Prosafe announced the award of a Conditional Letter of Intent by an undisclosed client for the provision to provide gangway connected operations to support a project off the coast of Western Australia for a firm period of 15 months with up to six months of options. Prosafe now advises that the contract has been signed. The Safe Boreas will mobilise from the North Sea within Q2 2025 and will undergo its five-yearly special periodic survey and other maintenance works prior to commencement of the contract. The value of the contract remains at approximately USD 75 million to USD 100 million depending on options. Terje Askvig, CEO of Prosafe says: “Formalising this contract has been a result of close and positive collaboration. Prosafe is confident that the Safe...

Grieg Seafood ASA: Q2 2024 results

Written by Customer Service on August 21, 2024. Posted in Earnings Releases And Operating Results.

Highlights – Harvest volume of 15,272 tonnes (22,645 tonnes).– Operational EBIT in the quarter of NOK -35 million (NOK 547 million), with operational EBIT/kg of NOK -2.3 (24.2).– BC results significantly impacted by biological event, also adversely affecting Q3 with an expected negative Operational EBIT in BC in the range of NOK 230 and 250 million.– Spiro impacted generation in Finnmark has been fully harvested in July 2024, after the balance sheet date.– Underlying production in Norway has been good towards the end of the quarter and into Q3.– Construction of post-smolt facilities in Rogaland, Finnmark and Newfoundland, and VAP facility at Gardermoen, are ongoing. Biomass investments on plan.– Uncertainty remains awaiting government decision on transition plan for Atlantic salmon aquaculture...

Strong operational second quarter for Mowi

Written by Customer Service on August 21, 2024. Posted in Earnings Releases And Operating Results.

(Bergen, 21 August 2024) Mowi generated EUR 1.34 billion in operating revenues in the second quarter which translated into an operational profit of EUR 230 million. Mowi generated EUR 1.34 billion in operating revenues in the second quarter which translated into an operational profit of EUR 230 million. The improvement in results from the previous quarter was driven by good operations across all business areas, including seasonal record-high growth in sea and reduced farming cost. “Mowi harvested a record 110,000 tonnes of salmon in the second quarter. At the same time our biomass in sea was at an all-time high level at the end of the quarter, and up by 9.4% from last year. This is impressive and shows that Mowi is well on track to deliver on our volume guidance of a milestone 500,000 tonnes this year. As recently as 2018 Mowi harvested...

Mowi med god drift i andre kvartal

Written by Customer Service on August 21, 2024. Posted in Earnings Releases And Operating Results.

(Bergen, 21. august 2024) Mowi rapporterte inntekter på 1,34 milliarder euro og et operasjonelt driftsresultat på 230 millioner euro i andre kvartal. Mowi oppnådde betydelige forbedringer i kvartalet som følge av gode operasjonelle prestasjoner, sesongmessig rekordhøye slaktevolumer og tilvekst, samt reduserte kostnader. – Mowi slaktet 110 000 tonn laks i andre kvartal, som er rekordhøyt for denne tiden på året. Samtidig har vi aldri hatt mer laks stående i sjø, 9,4% mer enn i fjor. Dette er imponerende og viser at vi ligger svært godt an til å nå vårt mål på 500 000 tonn for 2024. Så sent som i 2018 slaktet vi 375 000 tonn i Mowi, sier konsernsjef Ivan Vindheim. Volumvekst er en av bærebjelkene i Mowis strategi, og Vindheim er fornøyd med at selskapet nok en gang er forventet å vokse betydelig mer enn resten av næringen i 2024 med 5,3%...

Lerøy Seafood Group ASA: Continued progress in biological performance

Written by Customer Service on August 21, 2024. Posted in Earnings Releases And Operating Results.

PROGRESS IN BIOLOGICAL PERFORMANCE CONTINUES Lerøy Seafood Group ASA today reports a consolidated operational EBIT of NOK 906 million for the second quarter of 2024. CEO Henning Beltestad comments: “The positive trend in biological performance has continued into the second quarter, and we are performing well in a quarter characterized by declining salmon prices. The number of lice treatments has been significantly reduced, and growth and survival rates have substantially increased compared to the average over the past five years. Almost five years ago, we launched an extensive project to explore new technologies aimed at addressing one of the industry’s biggest challenges: the presence of sea lice and the related treatments that negatively affect fish welfare. In August 2024, we harvested our first salmon from submerged...

Conifex Provides Operational Updates

Written by Customer Service on August 21, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, Aug. 20, 2024 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”, “we” or “us”) (TSX: CFF) announced today that, in light of imminently expected transportation challenges that will affect all Canadian lumber producers for an unspecified period, together with already existing unfavourable market conditions, Conifex is reducing its sawmill operating schedule at its Mackenzie, British Columbia site to a one-shift basis for the foreseeable future and temporarily curtailing its power plant, each commencing on August 26, 2024. We anticipate an end to the curtailment of our power plant by September 30, 2024. On August 18, 2024, Canadian National Railway formally notified the Teamsters Canada Rail Conference (the “Union”) that it would begin locking out Union workers early on August 22, 2024, and...

Acceleware Invited to Pitch at Rice Alliance Energy Tech Venture Forum and Will Attend Houston’s Inaugural Energy and Climate Startup Week

Written by Customer Service on August 21, 2024. Posted in Public Companies.

CALGARY, Alberta, Aug. 20, 2024 (GLOBE NEWSWIRE) — Acceleware Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of transformative technologies targeting the decarbonization of industrial process heat, is very pleased to announce that it is one of 50 companies selected to pitch at the 21st Annual Rice Alliance Energy Tech Venture Forum, which is an anchor event for the Inaugural Energy and Climate Startup Week in Houston, Texas, September 9-13, 2024. The Energy Tech Venture Forum, hosted by The Rice Alliance for Technology and Entrepreneurship is the premier energy tech venture capital conference that connects energy innovators, investors, corporates and the energy ecosystem. This year’s forum will showcase promising energy companies driving the energy transition and technological advancements, along with...

Day: August 21, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice